tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
NYSE MKT:KAPA
US Market
Holding KAPA?
Track your performance easily

Kairos Pharma, Ltd. (KAPA) Income Statement

12 Followers

Kairos Pharma, Ltd. Income Statement

Last quarter (Q ), Kairos Pharma, Ltd.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q, Kairos Pharma, Ltd.'s net income was $-253.00K. See Kairos Pharma, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 796.00K$ 1.71M$ 571.00K
Operating Income
$ -796.00K$ -1.71M$ -571.00K
Net Non Operating Interest Income Expense
$ -43.00K$ -42.00K$ -71.00K
Other Income Expense
$ 49.00K$ 56.00K$ 408.00K
Pretax Income
$ -888.00K$ -1.81M$ -1.05M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -888.00K$ -1.81M$ -1.05M
Basic EPS
$ -0.08$ -0.16$ -0.10
Diluted EPS
$ -0.08$ -0.16$ -0.10
Basic Average Shares
$ 33.38M$ 11.03M$ 10.84M
Diluted Average Shares
$ 33.38M$ 11.03M$ 10.84M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 796.00K$ 1.71M$ 571.00K
Net Income From Continuing And Discontinued Operation
$ -888.00K$ -1.81M$ -1.05M
Normalized Income
$ -799.56K$ -1.33M$ -771.75K
Interest Expense
---
EBIT
$ -845.00K$ -1.77M$ -979.00K
EBITDA
$ -726.00K$ -1.55M$ -411.00K
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis